Highlights
KLSE: OPTIMAX (0222)       OPTIMAX HOLDINGS BERHAD ACE : Health Care
Last Price Today's Change   Day's Range   Trading Volume
1.00   0.00 (0.00%)  1.00 - 1.04  2,379,000
Trade this stock with T+7 trading account. Find out more.

Financials


Market Cap: 270 Million

Market Cap 270 Million
NOSH 270 Million

Latest Audited Result: 

Latest Audited Result:
Announcement Date
Next Audited Result:
Est. Ann. Date:
Est. Ann. Due Date:

Latest Quarter:  30-Sep-2020 [#3]

Latest Quarter: 30-Sep-2020 [#3]
Announcement Date 26-Nov-2020
Next Quarter: 31-Dec-2020
Est. Ann. Date: 26-Feb-2021
Est. Ann. Due Date: 01-Mar-2021
QoQ | YoY   4,225.00%  |    15.90%

Annual (Unaudited) ( EPS: - , P/E: 0.00 )

Revenue | NP to SH -  |  -
RPS | P/RPS -  Cent  |  0.00
EPS | P/E | EY -  Cent  |  0.00  |  0.00%
DPS | DY | Payout % -  Cent  |  0.00%  |  - %
NAPS | P/NAPS -  |  0.00
YoY   - %
NP Margin | ROE - %  |  - %
F.Y. | Ann. Date  | 

T4Q Result ( EPS: 2.15, P/E: 46.53 )

Revenue | NP to SH 56,878  |  5,803
RPS | P/RPS 21.07 Cent  |  4.75
EPS | P/E | EY 2.15 Cent  |  46.53  |  2.15%
DPS | DY | Payout % 0.00 Cent  |  0.00%  |  - %
NAPS | P/NAPS 0.17  |  5.88
QoQ | YoY   16.74%  |    - %
NP Margin | ROE 11.68%  |  12.64%
F.Y. | Ann. Date 30-Sep-2020  |  26-Nov-2020

Annualized Result ( EPS: 1.76, P/E: 56.82 )

Revenue | NP to SH 54,412  |  4,752
RPS | P/RPS 20.15 Cent  |  4.96
EPS | P/E | EY 1.76 Cent  |  56.82  |  1.76%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   145.20%  |    -42.89%
NP Margin | ROE 10.18%  |  10.35%
F.Y. | Ann. Date 30-Sep-2020  |  26-Nov-2020


Hints :
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.

Click here to modify the Visible Columns.

Date Financial Result Financial Ratio Per Share Item Performance Valuation (End of Quarter) Valuation (Ann. Date)
F.Y. Ann. Date Quarter # Revenue PBT NP NP to SH Div Net Worth Div Payout % NP Margin ROE NOSH RPS Adj. RPS EPS Adj. EPS DPS Adj. DPS NAPS Adj. NAPS QoQ YoY EOQ Date EOQ Price EOQ P/RPS EOQ P/EPS EOQ P/NAPS EOQ EY EOQ DY ANN Date ANN Price ANN P/RPS ANN P/EPS ANN P/NAPS ANN EY ANN DY
31-Dec-2020 26-Nov-2020 30-Sep-2020 3 18,192 3,959 2,928 2,595 - 45,900 - % 16.09% 5.65% 270,000 6.74 6.74 0.96 0.96 0.00 0.00 0.1700 0.17   4,225.00%   15.90% 30-Sep-2020 0.795 11.80 82.72 4.68 1.21% 0.00% 26-Nov-2020 0.765 11.35 79.60 4.50 1.26% 0.00%
31-Dec-2020 27-Aug-2020 30-Jun-2020 2 9,539 177 118 60 - 23,999 - % 1.24% 0.25% 200,000 4.77 3.53 0.03 0.02 0.00 0.00 0.1200 0.09   -93.40%   -97.60% 0.00 0.00 0.00 0.00 0.00% 0.00% 27-Aug-2020 0.79 16.56 2,633.33 6.58 0.04% 0.00%
31-Dec-2020 14-Aug-2020 31-Mar-2020 1 13,078 1,655 1,107 909 - 2,357,099 - % 8.46% 0.04% 270,000 4.84 4.84 33.67 33.67 0.00 0.00 8.7300 8.73   -59.40%   -39.36% 0.00 0.00 0.00 0.00 0.00% 0.00% 0.00 0.00 0.00 0.00 0.00% 0.00%
31-Dec-2019 30-Sep-2019 3 16,069 3,609 2,493 2,239 - - - % 15.51% - % 269,759 5.96 5.95 0.83 0.83 0.00 0.00 - -   -10.55%   - % 0.00 0.00 0.00 0.00 0.00% 0.00% 0.00 0.00 0.00 0.00 0.00% 0.00%
31-Dec-2019 30-Jun-2019 2 16,163 3,949 2,709 2,503 - - - % 16.76% - % 200,240 8.07 5.99 1.25 0.93 0.00 0.00 - -   66.98%   - % 0.00 0.00 0.00 0.00 0.00% 0.00% 0.00 0.00 0.00 0.00 0.00% 0.00%
31-Dec-2019 31-Mar-2019 1 13,581 2,372 1,744 1,499 - - - % 12.84% - % 2,699 503.01 5.03 55.52 0.56 0.00 0.00 - -   - %   - % 0.00 0.00 0.00 0.00 0.00% 0.00% 0.00 0.00 0.00 0.00 0.00% 0.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.


Analyze this stock with MQ Trader system
  3 people like this.
 
sharkdododo found some valuation for your reading!
https://jawplace.com/optimax-almost-perfect-vision/
21/08/2020 11:21 PM
su1801 Not to worry invest here....this counter potential stock...my personal TP rm1.00, 1.20, 1.55 and 2.00 but to hold mid term
22/08/2020 5:29 PM
su1801 This counter already survive more 20 years...health care specialty on eye disorder....For sure profit....
22/08/2020 5:30 PM
GorengHealthcare Pharma up Optimax also up?

All healthcare huat ar! hahahhahhaa
24/08/2020 4:05 PM
GorengHealthcare Optimax go go go!
25/08/2020 9:18 AM
JaBerry Banyak goreng
27/08/2020 11:36 AM
EatCoconutCanWin gao gao pian lao kao
27/08/2020 5:23 PM
thunderbird tomorrow habis lar......go go go to Holland
27/08/2020 6:09 PM
AlexZai Limit up
28/08/2020 6:53 AM
Thespike Looks very well supported. Will fly to Rm 1 once operator has collected enough
02/09/2020 5:09 PM
Long George TP RM1.30, still cheap

https://klse.i3investor.com/blogs/kenangaresearch/2020-09-03-story-h1513312332-Optimax_Holdings_Eyeing_Expansion_to_Boost_Growth.jsp
03/09/2020 2:00 PM
lch90 Shy shy Masuk a bit see. I like long term investment with good fundamental company
03/09/2020 4:28 PM
hockmenglai Optimax Holdings (OPTIMAX MK/BUY/RM0.81/Target Price: RM1.10)
1H20: Temporary Glitches By MCO; Good Growth Trajectory Ahead

*What’s New*
• *ACC expansion drives organic growth.* Optimax’s expansion plan includes upgrading both Klang and Seremban branches to Ambulatory Care Centre (ACC) in order to carry out cataract and refractive surgical procedures. Management sees the potential annual revenue generation from both ACCs to be closed to RM10m-12m from 2021F onwards (2019: RM1.3m). We gathered that Optimax’s organic growth comes from the growing number of ACC.

• *Earnings recovery in 2H20*. While 1H20 earnings dropped 77% yoy amid COVID-19 impact, management sees surgeries picked up encouragingly with surgeries conducted for the month of June and July have outpaced the average monthly level seen in 2019. Taking cues from management inputs and records in the past, we believe the healthy underlying demand for ophthalmologist services could pave the way for an earnings recovery in 2H20.

• *Good growth prospect with a 24% earnings CAGR for 2019-22F*. This will be underpinned by: a) additional revenue stream from the Seremban and Klang ACC, b) an average 23% revenue growth from both cataract and laser operations, and c) established market presence. Optimax is the key beneficiary of the growing trend of aging and myopic populations.

• *Maintained BUY with a higher target price of RM1.10* in tandem with earnings upgrade (raised 18% and 14% for 2021F-22F earnings). We also ascribed a higher 2021F PE from 20x to 25x. This is based on regional 2016-19 average PEG of 1.5x, and a 30% discount from the implied PE of 36x. Since our initiation with BUY, share price soared up 270% from its IPO price and 13% from our previous TP. That said, we believe the market might not have sufficiently priced in for its scarcity premium given its good value proposition.

Please see the attached file link:
https://research.uobkayhian.com/content_download.jsp?id=58627&h=3beeb3d3d3c61910b3b8822f439fc4d4
07/09/2020 9:47 AM
hockmenglai Buy buy buy! UOB upgraded TP 1.10!!
07/09/2020 9:47 AM
lch90 Looks like operator dumping
07/09/2020 3:00 PM
lch90 Where TP RM 1.1
08/09/2020 10:56 AM
lch90 Very fake write good things then share drop
08/09/2020 11:38 AM
lch90 Klci goes up this share no movement. Klci down, this counter first to go down
11/09/2020 2:40 PM
mf US 3027,054.0DERIVED06:50:03 | Futures-548.0
21/09/2020 6:50 PM
Thespike Accumulation phase completed...engine started.....get ready for rm 1.00
29/09/2020 8:58 PM
50Cents Post removed. Why?
08/10/2020 1:27 AM
lch90 Useless counter. Accumulator too weak. Too pussy
20/10/2020 7:19 PM
Sweetchocalates Untung chicken rice money. Will buy back if i see good momentum
20/11/2020 12:25 PM
thesteward Potentially second samaiden
20/11/2020 2:36 PM
Aisha Me too.
20/11/2020 6:56 PM
Sneakpeek tomorrow q sell at 1.04
24/11/2020 4:53 PM
lch90 Shit counter
27/11/2020 11:06 AM
Sneakpeek Go go RM 1.20
03/12/2020 10:37 AM
garychee8 looking good...buy
03/12/2020 11:27 AM
JaBerry Looking good
11/12/2020 9:36 AM
Vbslim Slow and steady counter. Long term will get great reward.
11/12/2020 1:51 PM
cytew Can it moves up to 1.0 today ?
14/12/2020 7:03 AM
chiahs Cytew-> Buy Vol up these 2 days, a good sign to move higher, even better if have some positive news to support :)
14/12/2020 5:28 PM
RainT what is long term potential of OPTIMAX ?
15/12/2020 12:02 PM
cytew Soon to break 1.0
23/12/2020 1:35 PM
thesteward Good
23/12/2020 3:14 PM
Thespike From the momentum, it is trending higher with the short term of RM 1 easily breached. Fundamentally a very sound Company with specialised business not easily replicated.
23/12/2020 8:10 PM
Lasereye2020 Just sold my lots, because the revenue will be bad when they release the 2020 reports, the number of cataract surgery has gone down by 40% and it is giving discounted prices (RM$2,800) to fight Top Vision and Vista.
28/12/2020 11:04 AM
bullgoup123 wow time for RM1 !
30/12/2020 3:05 PM
Thespike Definitely will hit rm 1 in Jan if not next week. Very little free float in the market & easy for operator to push share higher.
03/01/2021 12:18 AM
Thespike Seems like the Owners has long term plans for this Company.
03/01/2021 12:24 AM
bullgoup123 RM1 hit
04/01/2021 2:54 PM
GorengHealthcare optimax > supermax !!
05/01/2021 10:38 AM
RainT down non stop
11/01/2021 3:13 PM
bullgoup123 Optimaxxxx is back again
12/01/2021 2:54 PM
jun1920 stop selling, let it break ATH again
14/01/2021 12:52 PM
cytew Hitting new high again
20/01/2021 10:34 AM
trade101 Lost power during closing..hope tomorrow rebound
20/01/2021 9:46 PM
RainT cannot up

continue to down

big resistance
25/01/2021 3:23 PM
make_money_enough Technically will rebound by tomorrow. However still depend on the market sentiment.
25/01/2021 9:27 PM